Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Anti-Cancer Drugs
|
June 1, 1993
D-CECaT: a breakthrough for patients with neuroblastoma
A Donfrancesco, G Deb, A Angioni, et al.
Leukemia
|
April 1, 1994
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas
T Ahmed, P Cook, E Feldman, et al.
Cancer
|
May 15, 1981
Malignant schwannoma--clinical characteristics, survival, and response to therapy
P P Sordillo, L Helson, S I Hajdu, et al.
Anticancer Research
|
September 1, 1995
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age
A Donfrancesco, G Deb, C Dominici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
Amsacrine retains a special role supporting Food and Drug Administration approval
Z A Arlin, E J Feldman, P Cook, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Biological classification of cell lines derived from human extra-cranial neural tumors
C P Reynolds, M M Tomayko, L Donner, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Chromogranin A expression in childhood peripheral neuroectodermal tumors
M J Cooper, L J Helman, A E Evans, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1983
Uptake of ruthenium-labeled transferrin in healing wounds
L Helson, K Rosenspire, A Kapellaris, et al.
American Journal of Clinical Oncology
|
August 1, 1992
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma
A Donfrancesco, G Deb, C Dominici, et al.
Cancer
|
February 1, 1970
E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children
L Tallal, C Tan, H Oettgen, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Anti-Cancer Drugs
|
June 1, 1993
D-CECaT: a breakthrough for patients with neuroblastoma
A Donfrancesco, G Deb, A Angioni, et al.
Leukemia
|
April 1, 1994
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas
T Ahmed, P Cook, E Feldman, et al.
Cancer
|
May 15, 1981
Malignant schwannoma--clinical characteristics, survival, and response to therapy
P P Sordillo, L Helson, S I Hajdu, et al.
Anticancer Research
|
September 1, 1995
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age
A Donfrancesco, G Deb, C Dominici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
Amsacrine retains a special role supporting Food and Drug Administration approval
Z A Arlin, E J Feldman, P Cook, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Biological classification of cell lines derived from human extra-cranial neural tumors
C P Reynolds, M M Tomayko, L Donner, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Chromogranin A expression in childhood peripheral neuroectodermal tumors
M J Cooper, L J Helman, A E Evans, et al.
International Journal of Nuclear Medicine and Biology
|
January 1, 1983
Uptake of ruthenium-labeled transferrin in healing wounds
L Helson, K Rosenspire, A Kapellaris, et al.
American Journal of Clinical Oncology
|
August 1, 1992
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma
A Donfrancesco, G Deb, C Dominici, et al.
Cancer
|
February 1, 1970
E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children
L Tallal, C Tan, H Oettgen, et al.
Page
of 14